INNOVIVA, INC. Other Non-Current Liabilities
INNOVIVA, INC. (INVA) had Other Non-Current Liabilities of $67.28 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $67.28M.
- 2026-03-31: Other Liabilities, Noncurrent $69.10M.
- 2025-12-31: Other Liabilities, Noncurrent $66.09M.
- 2025-09-30: Other Liabilities, Noncurrent $57.43M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $67.28M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $69.10M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $66.09M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $57.43M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $60.02M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $62.01M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $64.28M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $71.45M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $72.06M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $71.69M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $71.87M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $68.69M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $68.58M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $70.13M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $70.92M 10-K/A · filed 2024-03-05 | |
| 2022-09-30 | $78.42M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.09M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $3.30M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2021-09-30 | $14.00K 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $45.00K 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $77.00K 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $106.00K 10-K/A · filed 2022-03-17 | |
| 2020-09-30 | $136.00K 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $163.00K 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $192.00K 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $219.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $217.00K 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $298.00K 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $379.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $586.00K 10-K · filed 2020-02-19 | |
| 2018-09-30 | $668.00K 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $752.00K 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $835.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $940.00K 10-K · filed 2019-02-19 | |
| 2017-09-30 | $1.05M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $1.16M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.27M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $1.38M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $1.60M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.64M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.78M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.86M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $1.85M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.75M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.95M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.82M 10-K · filed 2016-02-24 | $1.72M 10-K · filed 2015-02-27 |
| 2014-09-30 | $1.53M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $1.30M 10-Q · filed 2014-08-07 | |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |